Mati Therapeutics
PrivateLast Round
Series A
Oct 8, 2025
Total Funding Raised
$12.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mati Therapeutics operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Series A round in October 2025.
Mati Therapeutics is a healthcare company developing a non-invasive sustained drug delivery platform, the Evolute® Punctal Plug Delivery System, to treat ocular diseases such as glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mati Therapeutics Comparables
Compare Mati Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Freya Ophthalmics | 86% | |
| INEYE THERAPEUTICS S.A. | 85% | |
| Amorphex Therapeutics | 85% |
For institutional investors. Book with your work email.
Mati Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 8, 2025 | ||||
| Seed Round | Sep 12, 2025 | ||||
| Early Funding | May 11, 2019 | ||||
| Early Funding | Oct 1, 2018 | ||||
| Early Funding | Sep 30, 2014 | ||||
VC Round | Apr 8, 2013 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 123% MoM, reaching 2.1K.
- May 19, 2026
Monthly visitors increased 553% MoM.
For institutional investors. Book with your work email.
Mati Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mati Therapeutics's valuation, stock price, and market status.
Is Mati Therapeutics a public or private company?
Mati Therapeutics is a private company.
What is the current stock price of Mati Therapeutics?
Mati Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mati Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mati Therapeutics worth (valuation)?
Valuation information for Mati Therapeutics is not publicly available.
Can I buy Mati Therapeutics stock?
Mati Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mati Therapeutics's last funding round?
Mati Therapeutics's most recent funding round was Series A on October 8, 2025.
Who are the main investors in Mati Therapeutics?
Investor information for Mati Therapeutics is not publicly disclosed.
Will Mati Therapeutics IPO soon?
No public IPO plans have been announced for Mati Therapeutics.
How can I track Mati Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mati Therapeutics's shares on secondary markets.